HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity.

Abstract
Treatment of rats with recombinant human TNF initially causes a marked decrease in food intake, a loss of body weight, and a negative nitrogen balance. These alterations normalize with continued twice daily intraperitoneal injections of the same dose. Rats tolerized to TNF in this manner are refractory to a lethal dose of TNF. Also, TNF-pretreated and -tolerized rats have prolonged survival and reversed histopathologic changes after injection of a lethal dose of endotoxin compared with control animals. The TNF-tolerant state is dependent on the dose of TNF used and the length of TNF pretreatment. TNF-induced tolerance is relatively short lived, being present 2-4 d after TNF pretreatment and dissipating by 2 wk. Rats made tolerant to endotoxin are also tolerant to a lethal dose of TNF. A bidirectional crossreacting tolerance exists between TNF and endotoxin. The mechanism of TNF tolerance is unclear, but it does not appear to be due to a humoral immune response or a perturbation of the uptake and clearance of injected TNF.
AuthorsD L Fraker, M C Stovroff, M J Merino, J A Norton
JournalThe Journal of experimental medicine (J Exp Med) Vol. 168 Issue 1 Pg. 95-105 (Jul 01 1988) ISSN: 0022-1007 [Print] United States
PMID3294337 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Endotoxins
  • Immunoglobulin G
  • Immunoglobulin M
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Nitrogen
Topics
  • Animals
  • Body Weight
  • Drug Tolerance
  • Eating
  • Endotoxins (pharmacology, toxicity)
  • Escherichia coli
  • Immunoglobulin G (biosynthesis)
  • Immunoglobulin M (biosynthesis)
  • Kinetics
  • Male
  • Nitrogen (metabolism)
  • Rats
  • Rats, Inbred F344
  • Recombinant Proteins (pharmacology)
  • Tumor Necrosis Factor-alpha (administration & dosage, immunology, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: